Research from the Indiana University School of Medicine in Indianapolis analyzed data to look for trends in cancer survival among patients who are separated, divorced, widowed, and never married. The study, which gleaned data from the Surveillance Epidemiology and End Results (SEER) database, concludes that cancer patients who are separated at the time of diagnosis do not live as long as others.

Research shows that personal relationships impact physical health, namely that good relationships are beneficial and poor ones are detrimental. The study authors suggest that the stress of separation may compromise the immune system, creating an increased vulnerability to cancer and poor survival rates.

Gwen Sprehn, Ph.D., states “Identification of relationship-related stress at time of dagnosis could lead to early interventions which might favorably impact survival.” Additional research is needed, but researchers suggest certain actions, such as psychological interventions, might reduce stress, impacting the immune system and survival.

News source: http://www.eurekalert.org/pub_releases/2009-08/acs-cpw081909.php

Week of September 1, 2009

Alexander Rivkin, MD

Alexander Rivkin, MD is a Yale trained facial cosmetic surgeon and UCLA faculty member who focuses exclusively on providing the latest in non-invasive and non-ablative cosmetic treatments in Southern California. Dr. Rivkin is an international authority on non-surgical cosmetic treatments. He has been featured on the Today show, the Tyra Banks show, Extra, Univision, PBS, and in numerous national publications for the innovative procedures that he has invented. He was the first physician in the US to offer the Non-Surgical Nose Job, his signature method for non-invasive correction of cosmetic nasal irregularities.

At the upcoming Anti-Aging Conference: Clinical Applications for In-Office Procedures in San Jose, California (September 9-12, 2009), Dr. Rivkin will present, Needle vs. Knife: Update on the State of the Art in Non-Surgical Facial Sculpting, on Friday, September 11, 2009.

This presentation will provide a quick overview of the current techniques in non-surgical facial sculpting using injectable fillers and neurotoxins. Covered procedures will include non-surgical rhinoplasty, non-surgical cheek enhancement, non-surgical chin enhancement, and sculpting of the cheek and under eye area.

For more information call the A4M today; 1-888-997-0112.

Highlights from a presentation given by James L. Oschman, PhD at the 17th Annual World Congress on Anti-Aging and Regenerative Medicine entitled, Energetic Aspects of Aging.

At the upcoming Anti-Aging Conference: Clinical Applications for In-Office Procedures, Dr. Oschman will ch-chair a special workshop, entitled Energy Medicine on Wednesday, September 9th, 2009.

For more information, call; 1-888-997-0112.

James L. Oschman, Ph.D. is a cell biologist and biophysicist. He has published about 90 papers in both leading scientific journals and in complementary medicine journals. He has also written two books on energy medicine, and lectures internationally on the subject. His investigations of the living connective tissue matrix provide the basis for powerful applications of energetics to anti-aging medicine.

A study published in the Journal of Agricultural and Food Chemistry reports that root extracts from the vine kudzu help lower cholersterol, blood pressure, blood sugar and insulin levels.

Long used in China and Japan as a health food supplement, kudzu shows promise as a dietary supplement for metabloic syndrome which increases risk for heart attack, stroke and other disease. Individuals with obesity, high blood pressure, high cholesterol and problems with their body’s ability to absorb insulin may benefit from kudzu extracts.

Reasearch conducted at the University of Alabama indicates that the fast-growing vine once used to fight soil erosion “may provide a dietary supplement that significantly decreases the risk and severity of stroke and cardiovascualr disease in at-risk individuals.”

News source: http://www.timesoftheinternet.com/104959.html

Research from the University of Central Florida indentifies a gene that controls the development of fat cells. Monocyte Chemotactic Protein-1 Induced Protein (MCPIP) gives scientists a new direction for developing drugs that would prevent the body from becoming resistant to insulin and prone to type 2 diabetes.

MCPIP is a regulator of fat cell formation and blood vessel formation that feeds growing fat tissue. Predominance of fatty tissue contributes to the inability to process insulin, potentially triggering type 2 diabetes. Until recently, a different protein, known as peroxisome proliferator-activated receptor gamma (PPAR gamma) was thought to be the the master controller of fat cell formation.

The creation of new drugs that can block or slow down the formation of MCPIP has the potential to help hundreds of millions of people worldwide who are clinically obese and to dramatically reduce health care costs. Establishing chemical combinations effective at shutting down MCPIP will likely take several years, but researchers are encouraged by recent results.

News source: http://www.sciencedaily.com/releases/2009/08/090826110112.htm